Bone Cancer
- Home
- Bone Cancer
Bone Cancer
Bone cancer is a rare condition in which abnormal cells grow uncontrollably within bone tissue. The most common bone cancer symptoms are persistent bone pain, localised swelling, and fractures that occur after minimal trauma. When identified early, bone cancer can often be treated with surgery, chemotherapy, or radiation therapy, and in many cases the limb can be preserved.
Onco-Life Cancer Centre treats bone cancer across its four Maharashtra centres – Talegaon, Wagholi, Satara, and Chiplun – using a multidisciplinary team approach and NABH-accredited care standards.
This page explains bone cancer symptoms, types, causes, stages, diagnosis, and treatment options available at Onco-Life Cancer Centre. Please consult a qualified oncologist for a clinical assessment of any symptoms described here.
What Is Bone Cancer?
- Primary bone cancer: originates in the bone itself. This is relatively rare and is the main focus of this page.
- Secondary (metastatic) bone cancer: cancer that has spread to the bone from another site – such as the breast, prostate, or lung. Secondary bone cancer is more common than primary bone cancer.
Types of Bone Cancer
The three main types of primary bone cancer are:
Osteosarcoma
The most common primary bone cancer. It most often affects children, teenagers, and young adults, and typically develops near the knee (lower femur or upper tibia) or the upper arm bone (humerus). Osteosarcoma grows rapidly and often requires a combination of chemotherapy and surgery.
Ewing Sarcoma
More common in children and adolescents, Ewing sarcoma typically develops in the long bones of the arms and legs, the pelvis, or the ribs. Symptoms often include localised pain, swelling, and fever. Treatment usually involves chemotherapy, surgery, and sometimes radiation therapy.
Chondrosarcoma
A cancer arising in cartilage cells, chondrosarcoma most commonly affects adults over 40. It tends to grow more slowly than osteosarcoma or Ewing sarcoma. Surgery is the primary treatment, as chondrosarcoma responds less predictably to chemotherapy and radiation therapy. [Source: Requires Clinical Team Verification]
Less common types include fibrosarcoma, malignant fibrous histiocytoma, and chordoma.
Bone Cancer Symptoms: Warning Signs to Watch For
Bone cancer symptoms can be subtle in the early stages and are sometimes mistaken for sports injuries, growing pains in younger patients, or arthritis in older adults. The following symptoms, if persistent, warrant medical evaluation:
- Persistent or worsening bone pain: the most common symptom. The pain may be dull and aching at first, but typically becomes constant and is often worse at night or during physical activity.
- Swelling or a visible lump near a bone: a firm, sometimes tender swelling around the affected bone, particularly near the knee, upper arm, or pelvis.
- Fractures from minor injury (pathological fractures): bone weakened by a tumour may fracture with minimal force or trauma.
- Limited range of movement: difficulty moving a joint or limb if the tumour is near a joint.
- Limping or changes in gait: if the tumour affects the leg or pelvis.
- Unexplained fatigue or weight loss: particularly in more advanced or systemic disease.
- Fever (specifically in Ewing sarcoma): some patients with Ewing sarcoma develop a low-grade fever.
If any of these symptoms have been present for more than two weeks or are worsening, consult a doctor promptly. These symptoms do not confirm bone cancer – many have other explanations – but early evaluation is essential.
Is Bone Cancer Painful?
Yes. Pain is the most common and often the earliest symptom of bone cancer. The pain associated with bone cancer has a characteristic pattern: it tends to be persistent, deep, and aching, and is often worse at night or at rest. Unlike muscle pain caused by activity, bone cancer pain does not reliably improve with rest.
As the tumour grows, pain may intensify. In advanced cases, a pathological fracture – a break caused by the weakened bone – can produce sudden, severe pain. Pain management is an important part of bone cancer care at Onco-Life Cancer Centre, both during active treatment and through the palliative care programme for advanced disease.
Causes and Risk Factors for Bone Cancer
The exact cause of bone cancer is not fully understood in most cases. However, the following risk factors are associated with a higher likelihood:
- Genetic and hereditary syndromes: Li-Fraumeni syndrome, Rothmund-Thomson syndrome, and hereditary retinoblastoma are associated with a higher risk of osteosarcoma.
- Previous radiation therapy: high-dose radiation to bones – particularly during childhood cancer treatment – can increase the risk of developing bone sarcoma later in life.
- Paget’s disease of bone: a chronic bone condition associated with a small but elevated risk of developing osteosarcoma in older adults.
- Bone marrow or stem cell transplantation: recipients may have a marginally elevated risk.
- Previous benign bone conditions: certain non-cancerous bone tumours, such as enchondromas or osteochondromas, carry a small risk of malignant transformation.
The majority of bone cancer cases occur without a clearly identifiable cause. Injury or trauma to a bone does not cause bone cancer, although it may draw attention to a pre-existing tumour.
Stages of Bone Cancer
Bone cancer staging is used to determine how far the cancer has progressed and to guide treatment decisions. The standard staging system uses a combination of tumour grade, size, and extent of spread:
Stage | Grade | Description |
|---|---|---|
Stage I | Low grade | Tumour is confined to the bone and has not spread. Low-grade means cells look relatively normal and grow slowly. Stage IA is smaller; Stage IB involves a larger portion of the bone. |
Stage II | High grade | Tumour remains confined to the bone but consists of more abnormal, faster-growing cells. Higher risk of spread. Stage IIA is smaller; Stage IIB is larger. |
Stage III | High grade | High-grade tumour affecting multiple sites within the same bone. |
Stage IV | Any grade | Cancer has spread beyond the bone to other parts of the body, most commonly the lungs. Stage IVA involves lung spread; Stage IVB involves other distant sites. |
Lower stages generally have more favourable treatment outcomes. Staging is confirmed through imaging and biopsy results.
How Common Is Bone Cancer?
Primary bone cancer is rare. It accounts for less than 1% of all cancers globally. In India, precise incidence data from the Indian Council of Medical Research (ICMR) National Cancer Registry should be referenced here.
Primary bone cancer affects two distinct age groups most commonly:
- Children, adolescents, and young adults (ages 10 to 25): osteosarcoma and Ewing sarcoma are most prevalent in this group.
- Older adults (over 60): chondrosarcoma is more common in this age group.
Within younger age groups, primary bone cancer occurs more frequently in males than females.
Is Bone Cancer Curable?
Whether bone cancer can be cured depends on several factors, including the type of bone cancer, the stage at diagnosis, the patient’s age and overall health, and the response to treatment. This is a question that patients and families commonly ask, and the honest answer is that outcomes vary significantly.
- Localised osteosarcoma and Ewing sarcoma (Stages I and II): with combined chemotherapy and surgery, many patients achieve long-term remission.
- Chondrosarcoma: low-grade chondrosarcoma that is surgically removed with clear margins has a good long-term outlook. Higher-grade variants carry a higher risk of recurrence.
- Metastatic (Stage IV) bone cancer: treatment aims to control the disease and manage symptoms. Long-term remission is achievable in some cases, particularly in patients with limited metastases who respond well to treatment.
Bone cancer can return after treatment, particularly within the first five years. Regular follow-up is essential. The multidisciplinary team at Onco-Life Cancer Centre discusses each patient’s prognosis and treatment options in detail at the time of diagnosis.
This content is for informational purposes only and does not constitute a guarantee of outcome. Individual prognosis must be discussed with a qualified oncologist.
When to See a Doctor for Bone Cancer Symptoms
Consult a doctor promptly if you or a family member experiences any of the following:
- Bone pain that persists for more than two weeks, particularly if it worsens at night or does not improve with rest.
- A palpable lump or swelling near a bone or joint.
- A fracture caused by minimal force or a fall that would not normally cause a break.
- Unexplained limping or difficulty moving a limb.
- Persistent fever, fatigue, or unexplained weight loss alongside bone discomfort.
These symptoms have many possible causes. A clinical examination and imaging tests can quickly determine whether further investigation is needed. Onco-Life Cancer Centre offers rapid-access consultations at Talegaon, Wagholi, Satara, and Chiplun.
How Is Bone Cancer Diagnosed?
A bone cancer diagnosis requires a combination of clinical assessment, imaging, and tissue biopsy:
Imaging
- X-ray: the first investigation for suspected bone cancer. Abnormal bone architecture, cortical destruction, or a periosteal reaction may be visible.
- MRI (Magnetic Resonance Imaging): provides detailed imaging of soft tissue around the bone and helps define the extent of the tumour.
- CT scan (Computed Tomography): used to assess bone detail and screen for spread to the lungs.
- PET-CT scan (Positron Emission Tomography – Computed Tomography): used to detect distant spread and assess the metabolic activity of the tumour. Onco-Life Cancer Centre offers PET-CT scanning at its Talegaon centre.
- Bone scan (radionuclide scintigraphy): identifies areas of increased bone activity that may indicate tumour spread.
Tissue Biopsy
A biopsy is essential to confirm the diagnosis and determine the tumour type and grade. Biopsy must be planned carefully – the biopsy site should be chosen to avoid compromising subsequent surgery. At Onco-Life Cancer Centre, biopsies are performed by the surgical oncology team to ensure correct planning. Types include core needle biopsy and open (incisional) biopsy.
Laboratory Tests
- Blood tests: alkaline phosphatase (ALP) and lactate dehydrogenase (LDH) may be elevated in osteosarcoma and Ewing sarcoma respectively. [Source: Requires Clinical Team Verification]
- Bone marrow biopsy: required in some cases of Ewing sarcoma to assess marrow involvement.
Bone Cancer Treatment at Onco-Life Cancer Centre
Bone cancer treatment is planned by a multidisciplinary team including surgical oncologists, medical oncologists, radiation oncologists, radiologists, pathologists, and rehabilitation specialists. Treatment depends on the cancer type, grade, stage, and the patient’s overall health.
Surgery
- Limb-sparing (limb-salvage) surgery: the tumour is removed while preserving the affected limb. Reconstruction uses bone grafts, metal implants (endoprostheses), or a combination. This is possible in the majority of bone cancer cases today.
- Amputation: performed only when limb-sparing surgery is not oncologically safe. Onco-Life’s surgical oncology team evaluates every patient for limb-salvage options before considering amputation.
- Reconstruction and rehabilitation: after surgery, physiotherapy is essential for restoring function. Onco-Life’s rehabilitation programme includes physiotherapy, prosthetic fitting, and psychological support.
Chemotherapy
Chemotherapy is the cornerstone of treatment for osteosarcoma and Ewing sarcoma. It is used before surgery (neoadjuvant chemotherapy) to reduce the tumour size, and after surgery (adjuvant chemotherapy) to eliminate residual cancer cells and reduce the risk of recurrence. The response to pre-operative chemotherapy – assessed in the surgical specimen – is one of the most important prognostic factors.
Radiation Therapy
Radiation therapy is used primarily for Ewing sarcoma, for spinal or pelvic tumours where surgery is technically difficult, and for cases where complete surgical resection is not possible. Onco-Life Cancer Centre’s Talegaon centre offers TomoTherapy (Radixact X9), which delivers highly targeted radiation to the tumour with sub-millimetre precision, minimising dose to surrounding healthy tissue.
Targeted Therapy and Immunotherapy
Targeted therapy and immunotherapy are used in select bone cancer subtypes, particularly in advanced or recurrent disease. These treatments are assessed case by case by the multidisciplinary team. Some bone cancer subtypes may be eligible for clinical trials evaluating novel agents. Onco-Life Cancer Centre’s clinical trials programme can be discussed with the treating oncologist.
Palliative Care
For patients with advanced or metastatic bone cancer, Onco-Life’s palliative care programme provides pain management, symptom control, nutritional support, and psychological care. Palliative care is offered alongside active treatment and is not limited to end-of-life care.
Bone Cancer Prognosis and Outlook
The prognosis for bone cancer depends on the type, stage, grade, and response to treatment. The following information is provided as general guidance only. Individual prognosis should be discussed with a qualified oncologist.
- Osteosarcoma: localised disease treated with chemotherapy and surgery has a more favourable long-term outlook than metastatic disease.
- Ewing sarcoma: localised disease detected and treated early carries a better prognosis than disease with distant spread.
- Chondrosarcoma: low-grade, completely resected chondrosarcoma has a good long-term outcome. High-grade variants carry a higher recurrence risk.
- Metastatic bone cancer: outcomes depend on the number and location of metastases, the response to systemic treatment, and the patient’s overall health.
Bone cancer can recur after treatment, most commonly within the first five years. Regular follow-up imaging and clinical review are essential for all patients.
Bone Cancer Treatment Under Government Health Schemes (MJPJAY / PM-JAY)
Bone cancer treatment at Onco-Life Cancer Centre is covered under the following government health schemes, subject to eligibility criteria:
- Mahatma Jyotiba Phule Jan Arogya Yojana (MJPJAY): Maharashtra residents holding a valid ration card (yellow, orange, white, Antyodaya, or Annapurna) may be eligible for cashless treatment up to Rs. 5 lakh per family per year, covering bone cancer surgery, chemotherapy, and radiation therapy.
- Ayushman Bharat (PM-JAY): covers eligible families across India for oncology procedures including bone cancer treatment.
- CGHS (Central Government Health Scheme): available to central government employees and pensioners.
Eligibility criteria apply. Please verify your eligibility with the Onco-Life scheme desk before visiting.
Reducing Your Risk of Bone Cancer
Because most bone cancers have no clearly identifiable cause, there is no definitive way to prevent the condition. However, certain steps may reduce risk or aid in earlier detection:
- Minimise unnecessary radiation exposure: avoid diagnostic radiation that is not clinically indicated, and discuss risks with your doctor if radiation therapy to bone is being considered as part of another treatment.
- Genetic counselling: individuals with a family history of Li-Fraumeni syndrome, hereditary retinoblastoma, or other hereditary cancer conditions should discuss genetic screening with a specialist.
- Report persistent bone symptoms early: do not attribute unexplained or persistent bone pain or swelling to growing pains or minor injuries without medical evaluation.
- Attend follow-up care after previous cancer treatment: patients who have received radiation therapy as part of prior cancer treatment should discuss bone cancer surveillance with their oncologist.
Conclusion and Next Steps
Bone cancer is rare, but its symptoms – persistent bone pain, localised swelling, and fractures from minor injury – are important to recognise and act on promptly. The three main types – osteosarcoma, Ewing sarcoma, and chondrosarcoma – each have distinct patterns, affected age groups, and treatment approaches. When identified at an early stage, bone cancer can often be treated with limb-sparing surgery and chemotherapy, with the limb preserved in the majority of cases.
Onco-Life Cancer Centre’s multidisciplinary bone cancer team is experienced in the full range of bone cancer types and stages. If you or a family member has symptoms that concern you, an early consultation is the most important first step.
Book a Bone Cancer Consultation at Onco-Life Cancer Centre Call: +91 81281 24067 (Talegaon and Wagholi) | +91 77690 04343 (Satara) Request a Second Opinion: oncolifehospitals.com/patient-care/ Book Online: oncolifehospitals.com/book-doctor-appointment/ |
Frequently Asked Questions
Bone Cancer FAQs
Is Bone Cancer Common?
Primary bone cancer is rare, accounting for less than 1% of all cancers. Secondary bone cancer - cancer that has spread to the bone from another organ - is more common.
Is Bone Cancer Curable?
Outcomes depend on the type, stage, and response to treatment. Localised bone cancer treated promptly has a more favourable outlook than advanced disease. This question is best discussed with your oncologist, who can give you an assessment based on your specific diagnosis. Bone cancer treatment does not guarantee a cure.
What Are the Early Signs of Bone Cancer?
Persistent bone pain - especially pain that worsens at night or does not improve with rest - is the most common early sign. A firm swelling or lump near a bone or joint, and fractures from minimal trauma, are also warning signs. These symptoms warrant prompt medical evaluation.
Can Bone Cancer Be Mistaken for Growing Pains or Arthritis?
Yes. In younger patients, bone cancer pain is sometimes attributed to growing pains. In older adults, it may be dismissed as arthritis or a musculoskeletal injury. This is why unexplained, persistent bone pain or swelling should always be evaluated by a doctor.
What Is the Most Common Type of Bone Cancer in Children?
Osteosarcoma is the most common primary bone cancer in children and adolescents, followed by Ewing sarcoma.
How Is Bone Cancer Diagnosed?
Diagnosis requires imaging (X-ray, MRI, CT scan, and sometimes PET-CT) followed by a tissue biopsy. The biopsy must be performed by an experienced surgical oncologist to avoid compromising subsequent surgery.
Is Bone Cancer Painful?
Yes. Bone cancer typically causes persistent, deep, aching pain that is worse at night or at rest. Pain management is a central part of bone cancer care at Onco-Life Cancer Centre.
Does Bone Cancer Spread?
Yes. Advanced bone cancer can spread most commonly to the lungs, and sometimes to other bones or the liver. PET-CT imaging and CT of the chest are used to check for spread during staging.
Will I Lose My Limb?
Limb-sparing surgery is now possible in the majority of bone cancer cases. Amputation is considered only when the tumour cannot be safely removed while preserving a functional limb. Your surgical oncologist will discuss the options specific to your situation.
What Is the Role of TomoTherapy in Bone Cancer Treatment?
TomoTherapy (Radixact X9), available at Onco-Life Cancer Centre's Talegaon centre, delivers radiation with sub-millimetre precision. For bone cancers where radiation therapy is used - particularly Ewing sarcoma or pelvic tumours - this technology reduces the dose to surrounding healthy tissue.
